These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 9200654)

  • 1. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
    Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
    Diabetes; 1994 Sep; 43(9):1108-13. PubMed ID: 8070610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Smidt UM; Chen JW; Sato A; Parving HH
    Scand J Clin Lab Invest; 1997 Aug; 57(5):427-34. PubMed ID: 9279969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
    Tarnow L; Rossing P; Jensen C; Hansen BV; Parving HH
    Diabetes Care; 2000 Dec; 23(12):1725-30. PubMed ID: 11128341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
    Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.
    Bakris GL; Copley JB; Vicknair N; Sadler R; Leurgans S
    Kidney Int; 1996 Nov; 50(5):1641-50. PubMed ID: 8914031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.
    Tarnow L; Sato A; Ali S; Rossing P; Nielsen FS; Parving HH
    Diabetes Care; 1999 Mar; 22(3):491-4. PubMed ID: 10097934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria.
    Schnack C; Hoffmann W; Hopmeier P; Schernthaner G
    Diabetologia; 1996 Dec; 39(12):1611-6. PubMed ID: 8960851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.
    Rossing K; Jacobsen P; Pietraszek L; Parving HH
    Diabetes Care; 2003 Aug; 26(8):2268-74. PubMed ID: 12882847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
    Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J
    Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients.
    Velussi M; Brocco E; Frigato F; Zolli M; Muollo B; Maioli M; Carraro A; Tonolo G; Fresu P; Cernigoi AM; Fioretto P; Nosadini R
    Diabetes; 1996 Feb; 45(2):216-22. PubMed ID: 8549868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
    Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
    Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension.
    Samuelsson O; Hedner T; Ljungman S; Herlitz H; Widgren B; Pennert K
    Eur J Clin Pharmacol; 1992; 43(5):469-75. PubMed ID: 1336463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lisinopril and atenolol on aortic stiffness in patients on hemodialysis.
    Georgianos PI; Agarwal R
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):639-45. PubMed ID: 25784174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS.
    Leoncini G; Martinoli C; Viazzi F; Ravera M; Parodi D; Ratto E; Vettoretti S; Tomolillo C; Derchi LE; Deferrari G; Pontremoli R
    Nephron; 2002 Feb; 90(2):169-73. PubMed ID: 11818701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
    J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.
    Rossing K; Christensen PK; Jensen BR; Parving HH
    Diabetes Care; 2002 Jan; 25(1):95-100. PubMed ID: 11772908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.